0 Evaluaciones
ID

23210

Descripción

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Palabras clave

Versiones (2)
  1. 28/6/17 28/6/17 -
  2. 1/7/17 1/7/17 -
Subido en

28 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)CRFs Roche FVF4168G Macular Edema NCT00473330

    Inglés

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)CRFs Roche FVF4168G Macular Edema NCT00473330

    1 formularios  
    Patient administration
    Descripción

    Patient administration

    Subject Number
    Descripción

    PT

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Subject Initials:
    Descripción

    PTINIT

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C1997894
    UMLS CUI [1,2]
    C2986440
    Report Date:
    Descripción

    VDT

    Tipo de datos

    date

    Alias
    UMLS CUI [1,1]
    C1302584
    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)
    Descripción

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)

    Indicate if the subject completed the study drug treatment or discontinued early (check one only):
    Descripción

    TX_DRUG_DISC [TXDISC]

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C2826674
    Volver a la parte superior de la página

    Similar models

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)CRFs Roche FVF4168G Macular Edema NCT00473330

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Patient administration
    PT
    Item
    Subject Number
    integer
    C2348585 (UMLS CUI [1])
    PTINIT
    Item
    Subject Initials:
    text
    C1997894 (UMLS CUI [1,1])
    C2986440 (UMLS CUI [1,2])
    VDT
    Item
    Report Date:
    date
    C1302584 (UMLS CUI [1,1])
    Item Group
    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)
    Item
    Indicate if the subject completed the study drug treatment or discontinued early (check one only):
    integer
    C2826674 (UMLS CUI [1])
    TX_DRUG_DISC [TXDISC]
    Code List
    Indicate if the subject completed the study drug treatment or discontinued early (check one only):
    CL Item
    Subject Completed Study Drug Treatment (1)
    CL Item
    Subject Discontinued Study Drug Treatment Early (2)
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial